Very important pharmacogene summary: Sulfotransferase 1A1

Pharmacogenetics and Genomics

Volumn 19, Issue 6, 2009, Pages 404-406

  Hildebrandt, Michelle ^b   Adjei, Araba ^b   Weinshilboum, Richard ^b   Johnson, Julie A ^b   Berlin, Dorit S ^a   Klein, Teri E ^a   Altman, Russ B ^a  

^a STANFORD UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2,6 DICHLORO 4 NITROPHENOL; 4 HYDROXYESTRADIOL; 4 HYDROXYESTRONE; 4 NITROPHENOL; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; DIETHYLSTILBESTROL; ENZYME VARIANT; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRONE; MINOXIDIL; PARACETAMOL; SULFOTRANSFERASE 1A1; TAMOXIFEN DERIVATIVE; ARYL SULFOTRANSFERASE; SULT1A1 PROTEIN, HUMAN;

ALLELE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DRUG METABOLISM; ESOPHAGUS CANCER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; START CODON; BIOTRANSFORMATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

ARYLSULFOTRANSFERASE; BIOTRANSFORMATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS;

EID: 70149099023     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32832e042e     Document Type: Review

References (34)

1. Collins JE, Mungall AJ, Badcock KL, Fay JM, Dunham I. The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11. Genome Res 1997; 7:522-531.
2. Wilborn TW, Comer KA, Dooley TP, Reardon IM, Heinrikson RL, Falany CN. Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol 1993; 43:70-77.
3. Reiter C, Weinshilboum R. Platelet phenol sulfotransferase activity: correlation with sulfate conjugation of acetaminophen. Clin Pharmacol Ther 1982; 32:612-621.
4. Falany CN, Kerl EA. Sulfation of minoxidil by human liver phenol sulfotransferase. Biochem Pharmacol 1990; 40:1027-1032.
5. Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB J 1997; 11:206-216.
6. Adjei AA, Weinshilboum RM. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun 2002; 292:402-408.
7. Nishiyama T, Ogura K, Nakano H, Ohnuma T, Kaku T, Hiratsuka A, et al. Reverse geometrical selectivity in glucuronidation and sulfation of cis-and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases. Biochem Pharmacol 2002; 63:1817-1830.
8. Spink BC, Katz BH, Hussain MM, Pang S, Connor SP, Aldous KM, et al. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis 2000; 21:1947-1957.
9. Bonham Carter SM, Rein G, Glover V, Sandler M, Caldwell J. Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. Br J Clin Pharmacol 1983; 15:323-330.
10. Butler PR, Anderson RJ, Venton DL. Human platelet phenol sulfotransferase: partial purification and detection of two forms of the enzyme. J Neurochem 1983; 41:630-639.
11. Hernandez JS, Powers SP, Weinshilboum RM. Human liver arylamine N-sulfotransferase activity. Thermostable phenol sulfotransferase catalyzes the N-sulfation of 2-naphthylamine. Drug Metab Dispos 1991; 19:1071-1079.
12. Al-Buheissi SZ, Patel HR, Meinl W, Hewer A, Bryan RL, Glatt H, et al. N-acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation. Pharmacogenet Genomics 2006; 16:391-399.
13. Raftogianis RB, Her C, Weinshilboum RM. Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterization. Pharmacogenetics 1996; 6:473-487.
14. Dooley TP, Huang Z. Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16. Biochem Biophys Res Commun 1996; 228:134-140.
15. Hildebrandt MA, Salavaggione OE, Martin YN, Flynn HC, Jalal S, Wieben ED, Weinshilboum RM. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochem Biophys Res Commun 2004; 321:870-878.
16. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997; 239:298-304.
17. Raftogianis RB, Wood TC, Weinshilboum RM. Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 1999; 58:605-616.
18. Hildebrandt MA, Carrington DP, Thomae BA, Eckloff BW, Schaid DJ, Yee VC, et al. Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J 2007; 7:133-143.
19. Ning B, Nowell S, Sweeney C, Ambrosone CB, Williams S, Miao X, et al. Common genetic polymorphisms in the 50-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenet Genomics 2005; 15:465-473.
20. Hebbring SJ, Adjei AA, Baer JL, Jenkins GD, Zhang J, Cunningham JM, et al. Human SULT1A1 gene: copy number differences and functional implications. Hum Mol Genet 2007; 16:463-470.
21. Sun XF, Ahmadi A, Arbman G, Wallin A, Asklid D, Zhang H. Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation to colorectal cancer risk and patients' survival. World J Gastroenterol 2005; 11:6875-6879.
22. Dandara C, Li DP, Walther G, Parker MI. Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus. Carcinogenesis 2006; 27:791-797.
23. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 2001; 11:57-68.
24. Ozawa S, Shimizu M, Katoh T, Miyajima A, Ohno Y, Matsumoto Y, et al. Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. J Biochem 1999; 126:271-277.
25. Glatt H, Boeing H, Engelke CE, Ma L, Kuhlow A, Pabel U, et al. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001; 482:27-40.
26. Saintot M, Malaveille C, Hautefeuille A, Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer 2003; 107:652-657.
27. Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, et al. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenet Genomics 2005; 15:749-752.
28. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Wolf G, et al. Genetic variants of the sulfotransferase 1A1 and breast cancer risk. Breast Cancer Res Treat 2004; 87:19-22.
29. Han DF, Zhou X, Hu MB, Wang CH, Xie W, Tan XD, et al. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol Lett 2004; 150:167-177. (Pubitemid 38490524)
30. Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97:30-39.
31. Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2004; 13:270-276.
32. Steiner M, Bastian M, Schulz WA, Pulte T, Franke KH, Rohring A, et al. Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol 2000; 74:222-225.
33. Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, et al. Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. Int Urol Nephrol 2008; 40:947-951.
34. Kotnis A, Kannan S, Sarin R, Mulherkar R. Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer 2008; 99:1340-1347.